Correction: Galuzo et al. CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study. Viruses 2025, 17, 1233
Missing Institutional Review Board Statement
- Institutional Review Board Statement: The animal study protocol was approved by the Institutional Review Board (or Ethics Committee) of Fundação Oswaldo Cruz (protocol code P-6/20.3 (LW-17/20) on 6 July 2020 and renewed by protocol code 06/2024-3 (LBM-7/24) on 8 October 2024) by Bio-Manguinhos/Fundação Oswaldo Cruz. The protocol for the use of human samples was approved by the Institutional Review Board of Fundação Oswaldo Cruz (protocol code 34728920.4.0000.5262) on 3 November 2020.
Reference
- Galuzo, R.; Lazari Machado, T.; de Souza Nascimento, R.; Ramos de Medeiros, J.; Neves Tubarão, L.; Silva, J.; Pimenta Rocha, V.; Azamor, T.; Soares Coelho, F.; da Silva, A.M.V.; et al. CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study. Viruses 2025, 17, 1233. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Galuzo, R.; Lazari Machado, T.; de Souza Nascimento, R.; Ramos de Medeiros, J.; Neves Tubarão, L.; Silva, J.; Pimenta Rocha, V.; Azamor, T.; Soares Coelho, F.; da Silva, A.M.V.; et al. Correction: Galuzo et al. CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study. Viruses 2025, 17, 1233. Viruses 2025, 17, 1281. https://doi.org/10.3390/v17091281
Galuzo R, Lazari Machado T, de Souza Nascimento R, Ramos de Medeiros J, Neves Tubarão L, Silva J, Pimenta Rocha V, Azamor T, Soares Coelho F, da Silva AMV, et al. Correction: Galuzo et al. CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study. Viruses 2025, 17, 1233. Viruses. 2025; 17(9):1281. https://doi.org/10.3390/v17091281
Chicago/Turabian StyleGaluzo, Renan, Thiago Lazari Machado, Ryann de Souza Nascimento, Jorvan Ramos de Medeiros, Luciana Neves Tubarão, Jane Silva, Vanessa Pimenta Rocha, Tamiris Azamor, Felipe Soares Coelho, Andrea Marques Vieira da Silva, and et al. 2025. "Correction: Galuzo et al. CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study. Viruses 2025, 17, 1233" Viruses 17, no. 9: 1281. https://doi.org/10.3390/v17091281
APA StyleGaluzo, R., Lazari Machado, T., de Souza Nascimento, R., Ramos de Medeiros, J., Neves Tubarão, L., Silva, J., Pimenta Rocha, V., Azamor, T., Soares Coelho, F., da Silva, A. M. V., Carvalho da Rosa, L., da Silva, J. F. A., Santos, R. T., Müller, R., Várady, C. B. S., Ano Bom, A. P. D., Neves, P. C. d. C., & Melgaço, J. G. (2025). Correction: Galuzo et al. CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study. Viruses 2025, 17, 1233. Viruses, 17(9), 1281. https://doi.org/10.3390/v17091281